ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC32011-10mg |
|
134578-96-4 |
ONO4057 (ONO-LB457)
|
0 | C27H34O7 | |
GC32011-5mg |
|
134578-96-4 |
ONO4057 (ONO-LB457)
|
0 | C27H34O7 | |
GC32011-1mg |
|
134578-96-4 |
ONO4057 (ONO-LB457)
|
0 | C27H34O7 | |
GC32010-5mg |
|
408303-43-5 |
GW 766994 (GW 994)
|
0 | C21H24Cl2N4O3 | |
GC32010-10mg |
|
408303-43-5 |
GW 766994 (GW 994)
|
0 | C21H24Cl2N4O3 | |
GC32010-50mg |
|
408303-43-5 |
GW 766994 (GW 994)
|
0 | C21H24Cl2N4O3 | |
GC32010-100mg |
|
408303-43-5 |
GW 766994 (GW 994)
|
0 | C21H24Cl2N4O3 | |
GC32010-25mg |
|
408303-43-5 |
GW 766994 (GW 994)
|
0 | C21H24Cl2N4O3 | |
GC32009-20mg |
|
133012-00-7 |
Anti-inflammatory agent 2
|
0 | C26H30N2O4S | |
GC32009-10mg |
|
133012-00-7 |
Anti-inflammatory agent 2
|
0 | C26H30N2O4S | |
GC32009-5mg |
|
133012-00-7 |
Anti-inflammatory agent 2
|
0 | C26H30N2O4S | |
GC32009-1mg |
|
133012-00-7 |
Anti-inflammatory agent 2
|
0 | C26H30N2O4S | |
GC32008-5mg |
|
27530-67-2 |
Feretoside
|
0 | C17H24O11 | |
GC32007-100mg |
|
1558036-85-3 |
Btk inhibitor 2
|
0 | C24H25N5O3 | |
GC32007-50mg |
|
1558036-85-3 |
Btk inhibitor 2
|
0 | C24H25N5O3 | |
GC32007-10mg |
|
1558036-85-3 |
Btk inhibitor 2
|
0 | C24H25N5O3 | |
GC32007-5mg |
|
1558036-85-3 |
Btk inhibitor 2
|
0 | C24H25N5O3 | |
GC32007-10mM(1mLinDMSO) |
|
1558036-85-3 |
Btk inhibitor 2
|
0 | C24H25N5O3 | |
GC32006-20mg |
|
1149727-61-6 |
S1PR1-MO-1
|
0 | C25H29N3O3 | |
GC32006-10mg |
|
1149727-61-6 |
S1PR1-MO-1
|
0 | C25H29N3O3 | |